Physician profile
Richard Fine
NPI 1295702934
$8,261.46
in general payments reported to CMS, 2019-2025
22 companies · $666 in 2025
The $666 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $1,904 · 2021: $2,812 · 2022: $932 · 2023: $1,405 · 2024: $410 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696 · Consulting Fee: $575 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.83 |
| Consulting Fee | $575.00 |
| Education | $210.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $1,976.70 | 2019-2022 | |
| Endomagnetics LTD | $1,089.43 | 2021-2024 | Magtrace, Magseed |
| Merit Medical Systems INC | $1,077.95 | 2021-2025 | Savi Scout, Savi Brachy |
| Puma Biotechnology, INC. | $1,000.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $805.50 | 2021 | |
| Myriad Genetic Laboratories, INC. | $748.28 | 2021-2024 | Myrisk |
| Elucent Medical | $543.44 | 2020 | |
| Leica Microsystems INC. | $210.00 | 2023 | |
| Molli Surgical (US) INC | $196.67 | 2024 | |
| Dilon Technologies, INC. | $105.58 | 2025 | Hemoblast Bellows |
| Galvanize Therapeutics, INC | $105.20 | 2023 | Aliya System |
| Innovation Technologies INC | $87.73 | 2023-2025 | Irrisept |
| Bioptics, INC. | $79.50 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $47.86 | 2025 | Keytruda, Lynparza |
| Cardinal Health 414 LLC | $39.26 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $35.77 | 2020-2021 | |
| Daiichi Sankyo INC. | $26.08 | 2019 | |
| Stryker Corporation | $25.95 | 2025 | Molli, Spy-Phi System |
| Boston Scientific Corporation | $18.82 | 2025 | Patient Trial Kit |
| Avanos Medical | $14.64 | 2019 | |
| Exelixis INC. | $13.88 | 2024 | Cabometyx |
| Nalu Medical, INC. | $13.22 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Fine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.